When a patient is first diagnosed with prostate cancer and has had all the relevant tests to check the extent of the disease he will normally have an appointment with his doctor to discuss what is best. Prostate cancer treatment will depend on the extent of the cancer and on the intent of the treatment. For example early prostate cancers will be treated with surgery, radiotherapy or watchful waiting. Prostate cancer surgery is a definite possibility for many men in the early stages of the disease and so the subject should be discussed with the doctor. Late prostate cancers will be treated with hormone therapy, radiotherapy, chemotherapy or a mixture of all 3. Often patients will be given a choice of treatments by the doctor and the pros and cons of each option explained. There is no best cancer of prostate treatment because the treatment you receive will depend on the extent of your cancer.
PROSTATE CANCER RADIOTHERAPY (COMMONLY CALLED PROSTATE CANCER RADIATION TREATMENT)
Many men undergo radiotherapy as it is often regarded as the best prostate cancer treatment. This may be with the aim to cure the cancer or to shrink and control it depending on the stage. Often hormone treatment is given prior to radiation treatment to help reduce the size of the cancer and improve the rate of cure. Small cancers don't need this hormone pre-treatment.
TYPES OF PROSTATE CANCER RADIOTHERAPY
Radiotherapy is the treatment for cancer of the prostate with radiation. This is most often as X-rays which pass through the body and kill the cancer cells in its path known as "external beam radiotherapy". The alternative way to treat the prostate is from within the body using small radioactive sources known as "brachytherapy". Brachytherapy is only suitable for a small proportion of men with early prostate cancer and with a suitable sized prostate gland. It has the advantage of slightly fewer side effects during the treatment but would not be so effective at curing more bulky prostate cancers.
EXTERNAL BEAM RADIOTHERAPY FOR PROSTATE CANCER
The majority of men with cancer of the prostate will have this type of radiation treatment. It is given by a machine called a Linear Accelerator. This makes high energy X-rays which are good at killing cancer cells. Linear accelerators are worked by radiographers who will also help you get into the right position for your treatment and give you advice during your treatment.
For the treatment the patient has to lie on a thin couch, rather like those used in the CT or MRI scanners. The machine then moves around the patient to deliver X-rays from several different angles, all pointing towards the prostate gland. Each treatment takes approximately 10 minutes to give, and the full dose of treatment is spread out to be given every day over a few weeks. This helps to give a big enough dose to the prostate to kill the cancer whilst reducing the side effects of treatment.
To make sure you are in the correct position and the prostate is being treated properly either an X-ray picture or more usually an extra CT scan will be taken before treatment starts to locate the prostate gland accurately. At this time you will also be given several tattoos (tiny dots on the skin) so that when you lie on the couch for each treatment the radiographers can make sure you are lined up properly. This helps to make sure the prostate gland is treated fully and to reduce side effects.
Patients are not able to feel X-rays or even be aware that the treatment machine is on. However as patients go through the weeks of treatment there are a number of common side effects that can be expected. Most of these are short term side effects which slowly build up through the treatment, are worst at or just after the end of treatment and then improve quite quickly (within a few weeks). There are also some long-term or late side effects which can occur.
Prostate Cancer Radiation Treatment
The study, conducted in 2007 and reported in the Journal of Urology earlier this year, was led by Dr. Kathryn E. Richert-Boe, of Kaiser Permanente Northwest in Portland, Oregon. It's objectives were to determine whether differences existed in prostate cancer treatment received by white and African American men at a health maintenance organization where access to medical care (was) theoretically equal for all members and, if so, to determine the reasons for these differences. The study found that African American patients in the early stages of prostate cancer were less likely than white patients to receive aggressive treatment for their disease.
Researchers conducting the study compared the likelihood of treatment with curative intent (TCI) between the two races, adjusting for age, tumor grade, stage, and the presence of comorbid conditions. What the study revealed was that 82 percent of 158 white prostate cancer patients underwent surgical removal of the prostate gland or radiation therapy for their illness; these are considered more aggressive treatments for the disease. Conversely, only 71 percent of 79 African-American patients received the same type of treatment. Dr. Richert-Boe and the team of researchers investigated whether other factors such as tumor grade, age, overall patient health, and even insurance coverage might explain the difference in treatment; they did not.
Prostate cancer is a leading cancer among men in the United States. In the year 2004, over 189,000 men were diagnosed with the disease. When found early, either through a DRE exam or PSA blood test, treatment is often successful. However, if the cancer goes undetected and reaches advanced stages before it is discovered, effective treatment can be much more difficult.
Prostate cancer in the early stages is often not treated aggressively, because the disease is slow-growing. Many doctors choose to monitor tumor growth and development rather than to prescribe more drastic or aggressive measures early on. The study found that while African American men were just as likely to agree to more aggressive treatments such as surgery or radiation therapy, they were only offered those options in 85 percent of the cases, versus 91 percent for white men.
In the end, the study concluded African American men were less likely to receive TCI than white men. Reasons for the findings in the study are not immediately clear. Additional studies including a larger patient sample is thought to be needed at this point to reveal the true nature of racial disparities in prostate cancer treatment.
Both Adrian Jones & James Culp are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Adrian Jones has sinced written about articles on various topics from Property Sale, Property Guide and Types of Cancer. Adrian Jones writes on several forms of cancer. Further information is available on his website dealing with. Adrian Jones's top article generates over 18100 views. to your Favourites.
James Culp has sinced written about articles on various topics from Health Insurance, Types of Cancer and Auto Insurance. James Culp is a prostate cancer survivor and runs ProstAide.org, a blog that keeps track of all the available.. James Culp's top article generates over 14800 views. to your Favourites.
Bait For Surf Fishing Surf fishing is an enjoyable hobby that will get you out of the house and maybe even offer up a chance to come home with fresh dinner